Product NewsFDA Grants Priority Review Status to TopoTarget’s Application for Approval of Totect™ (Savene™)
Product NewsTopoTarget Announces New Preclinical Results with Belinostat to be presented at AACR Annual Meeting
Product NewsTopoTarget’s new antidote for accidental tissue exposure during chemotherapy, Savene™, becomes 'gold standard'
Product NewsTopoTarget and CuraGen Initiate NCI-sponsored Phase II Clinical Trial of PXD101 for Acute Myelogenous Leukemia
Product NewsEMEA, the European Medicines Agency, recommends that the EU Commission should grant TopoTarget European marketing authorisation for Savene™
Product NewsTopoTarget and CuraGen present encouraging new preclinical data on PXD101 at the AACR 97th Annual Meeting
Product NewsTopoTarget and CuraGen announce initiation of first NCI-sponsored clinical trial with PXD101
Product NewsTopoTarget initiates pivotal Phase II trial with Savicol™ for FAP (an inherited pre-disposition to develop colon cancer)
